March 1, 2018 / 6:35 AM / 7 months ago

BRIEF-Novartis to develop digital MS, schizophrenia therapeutics with Pear Therapeutics

March 1 (Reuters) - Novartis Ag:

* NOVARTIS AND PEAR THERAPEUTICS TO DEVELOP DIGITAL THERAPEUTICS FOR PATIENTS WITH SCHIZOPHRENIA AND MULTIPLE SCLEROSIS

* NOVARTIS INVESTED IN PEAR'S SERIES B ROUND OF FINANCING ANNOUNCED IN JANUARY 2018 Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below